Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Oregano and Oregano-drug Interactions
NCT06693960Phase 1Recruiting
- Sponsor
- Washington State University
- Start
- Sep 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial (4 arms), sponsored by Washington State University. Primary endpoint: Midazolam Area under the plasma concentration vs. time curve ratio. Started Sep 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06693960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06693960.